<DOC>
	<DOCNO>NCT02497391</DOCNO>
	<brief_summary>The purpose study determine difference way body handle 3 type evacetrapib tablet different particle size . Information side effect also collect . This study consist 3 study period . Participants dose 3 time entire study . Each study period consist inpatient stay 3 day - day dosing ( Day -1 ) , dose day ( Day 1 ) day dose ( Day 2 ) . Then participants asked return clinical research unit ( CRU ) daily outpatient appointment Day 8 . The overall length study 7 week first dose end study . Screening take place within 28 day prior first dose evacetrapib follow-up take place 21 day last dose evacetrapib .</brief_summary>
	<brief_title>A Study Different Particle Sizes Evacetrapib Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Evacetrapib</mesh_term>
	<criteria>Overtly healthy participant nonchild bear potential Have body mass index 18 32 kilogram per square meter ( kg/m^2 ) Must willing make oneself available whole study willing follow study procedure Have know allergy evacetrapib , compound component related drug , history significant allergic reaction another origin .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>